Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$358K Buy
12,751
+889
+7% +$23.7K 0.18% 121
2025
Q4
$295K Buy
11,862
+1,679
+16% +$42.3K 0.15% 129
2025
Q3
$259K Buy
10,183
+5,541
+119% +$137K 0.1% 175
2025
Q2
$113K Sell
4,642
-4,099
-47% -$95.6K 0.06% 244
2025
Q1
$222K Buy
8,741
+63
+0.7% +$1.65K 0.09% 215
2024
Q4
$230K Buy
+8,678
New +$235K 0.11% 184

Other funds holding PFE

AmeriFlex Group's PFE Position: Q1 2026 in Review

AmeriFlex Group increased its Pfizer (PFE) stake by 7.5% in Q1 2026, buying an estimated $23.7K and bringing the position to 12,751 shares worth $358K. The position accounts for 0.18% of the portfolio, ranked #121.

AmeriFlex Group first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • AmeriFlex Group held 12,751 shares of Pfizer worth $358K as of Q1 2026.
  • AmeriFlex Group bought 889 Pfizer shares in Q1 2026, an estimated $23.7K.
  • Pfizer made up 0.18% of AmeriFlex Group's portfolio in Q1 2026, its #121 holding.
  • AmeriFlex Group first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on AmeriFlex Group's 13F filing for Q1 2026, filed 15 May 2026.